Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study
Introduction: Several studies have reported that intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are associated with extra-pancreatic malignancies. However, there have been no population-based studies evaluating the risk of second primary cancers (SPCs) in patients with pancreatic I...
Main Authors: | Xiaoyi Huang, Bingbing Zhang, Jian Zhao, Chen Sun, Kaiwen Kong, Lulu Deng, Yanfang Liu, Jianming Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00610/full |
Similar Items
-
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype
by: Paola Mattiolo, et al.
Published: (2020-08-01) -
Sites of Distant Metastases and Cancer-Specific Survival in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma: A Study of 1,178 Patients
by: Xiaoyi Huang, et al.
Published: (2021-06-01) -
Cystic lesion of pancreas - Intraductal papillary mucinous neoplasm
by: Rajiv Baijal, et al.
Published: (2013-07-01) -
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
by: Vincenzo Nasca, et al.
Published: (2020-09-01) -
Intraductal papillary mucinous neoplasms and mucinous cystadenomas: current status and recommendations
by: Maria Moris, et al.